Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Deferred Taxes: 2009-2024

Historic Deferred Taxes for Pediatrix Medical (MD) over the last 16 years, with FY2024 value amounting to -$2.1 million.

  • Pediatrix Medical's Deferred Taxes rose 2172.06% to $11.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.0 million, marking a year-over-year increase of 31085.3%. This contributed to the annual value of -$2.1 million for FY2024, which is 16576.1% down from last year.
  • Latest data reveals that Pediatrix Medical reported Deferred Taxes of -$2.1 million as of FY2024, which was down 16576.1% from $3.2 million recorded in FY2023.
  • In the past 5 years, Pediatrix Medical's Deferred Taxes registered a high of $36.3 million during FY2020, and its lowest value of -$31.2 million during FY2021.
  • In the last 5 years, Pediatrix Medical's Deferred Taxes had a median value of -$2.1 million in 2024 and averaged -$3.3 million.
  • Its Deferred Taxes has fluctuated over the past 5 years, first surged by 16513.87% in 2020, then plummeted by 18607.68% in 2021.
  • Pediatrix Medical's Deferred Taxes (Annual) stood at $36.3 million in 2020, then tumbled by 186.08% to -$31.2 million in 2021, then grew by 27.11% to -$22.8 million in 2022, then skyrocketed by 114.22% to $3.2 million in 2023, then tumbled by 165.76% to -$2.1 million in 2024.
  • Its Deferred Taxes stands at -$2.1 million for FY2024, versus $3.2 million for FY2023 and -$22.8 million for FY2022.